Newsbenzinga
Harrow Announces Agreement To Acquire Dry Eye Nasal Spray TYRVAYA From Viatris For $30M Cash At Closing, Up To $70M In Sales Milestones
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…